FK960 clinical trial

  • Owens, David (Principal Investigator)
  • Laidlaw, Ken (Co-investigator)

Project Details

StatusFinished
Effective start/end date1/02/02 → 30/06/05

Funding

  • UK industry, commerce and public corporations: £59,387.00
  • UK industry, commerce and public corporations: £294,375.00